Conmed (CNMD) Tops Q4 EPS by 1c, Offers FY Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/13/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Super Micro Computer establishes $1.25 billion stock sale agreement
- Wall Street ends higher as SpaceX's market debut dominates
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SpaceX Shares Indicated To Open At $155
CONMED Corporation Announces Fourth Quarter and Full-Year 2018 Financial Results
January 22, 2019 4:01 PM ESTUTICA, N.Y.--(BUSINESS WIRE)-- CONMED Corporation (Nasdaq: CNMD) today announced financial results for the fourth quarter and full year ended December 31, 2018.
Fourth Quarter 2018 Highlights
Sales of $242.4 million increased 8.9% year over year as reported and 10.8% in constant currency and as adjusted(1). Domestic revenue increased 10.5% year over year as reported and 12.9% as adjusted(1). International revenue increased 7.3% as reported and 8.7% in constant currency. Diluted net earnings per share (GAAP) were $0.54, compared to... More